
Integrated Data Management for Multicentric Imaging in Investigator-Initiated Trials (IITs)
Establishing a Framework for Multicentric Data Coordination
For many investigators, the transition from a single-site study to a multicentric model…

For many investigators, the transition from a single-site study to a multicentric model…


Following the FDA’s recent analysis of the growth rate constant (g) as a prognostic marker1, the challenge for many research organizations is…

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

Seminar in Radiological Diagnostics: "RSNA Update – Heart and Lung Imaging"

The recent study “Artificial intelligence for TNM staging in NSCLC – a critical appraisal of segmentation utility in [¹⁸F]FDG PET/CT” provides a…

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?


Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…